CN110444268B - Method and equipment for determining detail data of hemodialysis medicine - Google Patents
Method and equipment for determining detail data of hemodialysis medicine Download PDFInfo
- Publication number
- CN110444268B CN110444268B CN201910722704.2A CN201910722704A CN110444268B CN 110444268 B CN110444268 B CN 110444268B CN 201910722704 A CN201910722704 A CN 201910722704A CN 110444268 B CN110444268 B CN 110444268B
- Authority
- CN
- China
- Prior art keywords
- hemodialysis
- drug
- data
- management system
- determining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- General Business, Economics & Management (AREA)
- Epidemiology (AREA)
- Business, Economics & Management (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- External Artificial Organs (AREA)
Abstract
The invention discloses a method and equipment for determining detailed data of hemodialysis drugs, wherein a blood purification information system, a drug management system and an electronic medical record system are connected through an enterprise service bus and are provided with a unified patient master index, and the method comprises the following steps: determining detailed data to be claimed of hemodialysis drugs corresponding to a special prescription in the drug management system according to the special prescription; determining claim detail data for the hemodialysis medication based on results of actual verification and cancellation; determining consumption profile data for the hemodialysis medication in the medication management system; and determining the detail data of the hemodialysis medicine according to the detail data to be claimed, the detail data to be claimed and the consumption detail data, so that a patient main index is connected and set through an enterprise service bus, data channels of various medical systems are opened, the whole medication flow management and control of hemodialysis patients are realized, and the consistency of actual drug inventory and system inventory data is ensured.
Description
Technical Field
The invention relates to the technical field of medical informatization, in particular to a method and equipment for determining detailed data of hemodialysis drugs.
Background
According to official statistics, Chinese chronic kidney disease patients reach 1.3 billion, and 200 ten thousand of them will develop into "end stage" kidney disease patients, also known as uremia patients. Without the possibility of renal transplantation therapy, this part of patients will rely lifelong on dialysis therapy to sustain life and continue to the end of life. Hemodialysis patients are called hemodialysis patients for short, the type of the hemodialysis patients is set from the perspective of an information system in daily hemodialysis treatment, the hemodialysis patients belong to a special patient type and do not belong to outpatients in the common sense or hospitalized patients, the hemodialysis patients need to go to a blood purification center of a hospital for hemodialysis at fixed date and time every week, and a necessary link in the hemodialysis treatment is the use of dialysis medicines.
With the popularization of informatization in hospitals, specialized information systems are popularized and applied to a greater extent, in recent years, various hospitals successively come on line with blood purification systems, and although the software system framework design, database types and the like of each hemodialysis software manufacturer are slightly different, the realized functions are different greatly. As a relatively mature hemodialysis management system, the closed-loop management of the whole process from scheduling to thorough transfer of a patient can be basically completed, but because hemodialysis patients are different from outpatients and inpatients, the closed-loop management of the whole process for prescribing a medicine, checking and marketing a medicine, prescribing a dialysis medicine by a doctor and executing the medicine by a nurse is still not completed at present, so that detailed data of the hemodialysis medicine cannot be accurately determined, and further the supervision of the hemodialysis medicine is vulnerable to the following aspects:
(1) most hemodialysis patients are medical insurance patients, and because of the particularity of regional medical insurance policies (according to the medical insurance policy of Zhenjiang city, the medical expenses required for treating cancer and performing renal dialysis exceed the medical expenses meeting the requirements above the payment standards, the patients are paid by social overall fund, namely the self-cost of the patients exceeds the billing base by more than 14%, and the medicine expenses can be reported by 100% or 80% medical insurance), the number of hemodialysis medicines of the hemodialysis patients is not limited, so that a large number of hemodialysis medicines can be accumulated in the hemodialysis patients, and according to the statistical analysis of data, some patients have two years of hemodialysis medicines in one month.
(2) Because of the particularity of dialysis drugs, when hemodialysis patients are prescribed in hospitals, hospitals do not allow the patients to take the drugs home, the drugs are managed by the hospitals, the hospitals only distribute drug receiving certificates of the drugs of the patients, the drugs of outpatient clinics are still stored in the pharmacies after the patients are checked out, the precise number of the drugs cannot be checked by the pharmacies, and meanwhile, when the dialysis drugs of the hemodialysis patients pass through the drug receiving cards to the outpatient clinics to receive the corresponding drugs, the drugs cannot be counted out by the drugs due to the fact that the drug receiving cards only have the drug name information and do not have the personal information of the drug receiving patients.
(3) Outpatient pharmacy stores a large amount of medicines but cannot consume the medicines in time, so that overdue phenomena of the medicines are caused.
(4) The patient holds the medicine-receiving plate of the hemodialysis medicine, and the phenomena of breakage, loss and resale easily occur.
Disclosure of Invention
The invention provides a method for determining transparent data of hemodialysis drugs, which is used for solving the technical problems that the actual inventory of the hemodialysis drugs is inconsistent with the inventory data of a system and the supervision of the hemodialysis drugs has a leak in the prior art, wherein a blood purification information system, a drug management system and an electronic medical record system are connected through an enterprise service bus and are provided with a unified patient master index, and the method comprises the following steps:
determining detail data to be claimed of hemodialysis drugs corresponding to a special prescription in the drug management system according to the special prescription, wherein the special prescription is pushed into the drug management system by the electronic medical record system;
determining claim detail data of the hemodialysis drug based on a result of actual verification and cancellation, wherein the actual verification and cancellation are performed on pharmacy storage of the hemodialysis drug in the drug management system after a claim operation corresponding to the special prescription is completed;
determining consumption profile data for the hemodialysis medication in the medication management system, wherein the consumption profile data is pushed into the medication management system by the blood purification information system;
and determining the detail data of the hemodialysis medicine according to the detail data to be claimed, the detail data to be claimed and the consumption detail data.
Preferably, the special prescription list includes a patient identifier and prescription information of the hemodialysis drug, and the detailed data to be claimed of the hemodialysis drug corresponding to the special prescription list in the drug management system is determined according to the special prescription list, specifically:
virtually checking the hemodialysis medication in the medication management system based on the special prescription order;
determining the itemized data to be claimed based on the result of the virtual core cancellation.
Preferably, after the virtual verification of the hemodialysis drug in the drug management system based on the special prescription, the method further includes:
pushing the special prescription in the drug management system to the blood purification information system;
and updating detailed data to be claimed of the hemodialysis medicine in the blood purification information system according to the special prescription.
Preferably, before determining details to be claimed of the hemodialysis drug corresponding to a special prescription in the drug management system according to the special prescription, the method further includes:
determining patient identification and medicine-opening quantity in an electronic prescription established by a doctor in an electronic medical record system;
judging whether the patient is a hemodialysis patient or not according to the patient identifier;
if yes, judging whether the annual prescription quantity corresponding to the prescription quantity exceeds the annual prescription upper limit of the hemodialysis medicine corresponding to the patient;
if not, generating the special prescription list in the electronic medical record system according to the electronic prescription list;
and pushing the special prescription list to the medicine management system.
Preferably, the determining, by using a regression analysis method, an upper limit of an annual drug volume for each hemodialysis drug corresponding to the hemodialysis patient, and when it is determined that the annual drug volume corresponding to the drug volume exceeds the upper limit of the annual drug volume for the hemodialysis drug corresponding to the patient, the determining further includes:
and prompting to reopen the prescription list in the electronic medical record system.
Preferably, before determining the consumption detail data of the hemodialysis drug in the drug management system, the method further comprises:
updating the consumption detail data of the patient in the blood purification information system according to the medicine use condition of the patient;
pushing the consumption detail data in the blood purification information system to the drug management system.
Preferably, after determining the detail data of the hemodialysis drug from the details data to be claimed, and the consumption detail data, the method further includes:
receiving a query request sent by the patient through a client;
providing the patient with the detailed data of the hemodialysis medication according to the query request.
Correspondingly, the invention also provides a device for determining the detailed data of hemodialysis drugs, wherein the blood purification information system, the drug management system and the electronic medical record system are connected through an enterprise service bus and set a unified patient master index, and the device comprises:
the first determination module is used for determining detailed data to be claimed of hemodialysis drugs corresponding to a special prescription in the drug management system according to the special prescription, wherein the special prescription is pushed into the drug management system by the electronic medical record system;
a second determination module, configured to determine claim detail data of the hemodialysis drug based on a result of actual verification and cancellation, where the actual verification and cancellation are performed on pharmacy storage of the hemodialysis drug in the drug management system after a claim operation corresponding to the special prescription is completed;
a third determination module for determining consumption profile data of the hemodialysis drug in the drug management system, wherein the consumption profile data is pushed into the drug management system by the blood purification information system;
a fourth determining module, configured to determine detail data of the hemodialysis drug according to the to-be-claimed detail data, the claim detail data, and the consumption detail data.
Accordingly, the present invention also proposes a computer-readable storage medium having stored therein instructions that, when run on a terminal device, cause the terminal device to perform the method of determining hemodialysis drug detail data as described above.
Accordingly, the present invention also proposes a computer program product which, when run on a terminal device, causes the terminal device to execute the method of determining hemodialysis drug detail data as described above.
Compared with the prior art, the invention has the following beneficial effects:
through using above technical scheme, blood purifies information system, medicine management system and electronic medical record system and passes through the connection of enterprise service bus and set up unified patient's main index, include: determining detailed data to be claimed of hemodialysis drugs corresponding to a special prescription in the drug management system according to the special prescription; determining claim detail data for the hemodialysis medication based on results of actual verification and cancellation; determining consumption profile data for the hemodialysis medication in the medication management system; and determining the detail data of the hemodialysis drug according to the detail data to be claimed, the detail data to be claimed and the consumption detail data, so that an enterprise service bus is used for connecting and setting a patient main index, all medical system data channels are opened, the full-flow control of the hemodialysis patient drug administration is realized through a special prescription order and a virtual verification and marketing technology, the consistency of actual drug inventory and system inventory data is ensured, and the drug management efficiency and the patient satisfaction are improved.
Drawings
Fig. 1 is a schematic flow chart of a method for determining hemodialysis drug detail data according to an embodiment of the present invention;
FIG. 2 is a schematic flow chart of a method for determining hemodialysis drug detail data in an exemplary application scenario of the present invention;
FIG. 3 is a schematic flow chart illustrating the determination of hemodialysis drug details in an exemplary application scenario of the present invention;
FIG. 4 is a schematic flow chart illustrating the generation of a special prescription in an exemplary application scenario of the present invention;
FIG. 5 is a schematic flow chart of the blood purification information system updating detail data to be claimed in the context of an embodiment of the present invention;
FIG. 6 is a flow chart illustrating the determination of hemodialysis drug claim detail data in an exemplary application scenario of the present invention;
FIG. 7 is a flow chart illustrating the determination of hemodialysis drug consumption detail data in an exemplary application scenario of the present invention;
FIG. 8 is a schematic view of the flow of a hemodialysis medication in an embodiment of the present invention;
fig. 9 is a schematic structural diagram of an apparatus for determining hemodialysis drug detail data according to an embodiment of the present invention.
Detailed Description
As described in the background art, the actual inventory of hemodialysis drugs in the prior art is inconsistent with the inventory data of the system, and the supervision of hemodialysis drugs has a leak.
In order to solve the above problems, the embodiment of the present application provides a method for determining hemodialysis drug detail data, which implements hemodialysis patient drug administration full-process management and control through a special prescription order and a virtual verification and marketing technology, ensures consistency of actual drug inventory and system inventory data, and improves drug management efficiency and patient satisfaction.
As shown in fig. 1, a flow diagram of a method for determining transparent data of hemodialysis drugs according to an embodiment of the present invention is shown, in which a blood purification information system, a drug management system, and an electronic medical record system are connected via an enterprise service bus and set a unified patient master index, and connected via the enterprise service bus and set a patient master index, and access data channels of medical systems to implement information interaction among the three systems, and the method includes the following steps:
s101, determining detailed data to be claimed of hemodialysis drugs corresponding to a special prescription in the drug management system according to the special prescription, wherein the special prescription is pushed to the drug management system by the electronic medical record system.
Specifically, as described in the background art, hemodialysis drugs have specificity compared with ordinary drugs, and therefore, a special prescription is required to be set for hemodialysis drugs in the drug-setting process, details of the hemodialysis drugs to be claimed can be determined according to the special prescription, and the special prescription is generated in an electronic medical record system and is pushed to a drug management system by the electronic medical record system through an enterprise service bus.
In order to accurately determine the details data to be claimed of the hemodialysis drug, in a preferred embodiment of the present application, the special prescription slip includes a patient identifier and the prescription information of the hemodialysis drug, and the details data to be claimed of the hemodialysis drug corresponding to the special prescription slip in the drug management system is determined according to the special prescription slip, specifically:
virtually checking the hemodialysis medication in the medication management system based on the special prescription order;
determining the itemized data to be claimed based on the result of the virtual core cancellation.
As described above, the special prescription includes the patient identifier and the prescription information of the hemodialysis drug, in a specific application scenario of the present application, the drug management system receives the special prescription from the electronic medical record system, the patient goes to the pharmacy to take the drug before completing payment, the pharmacist checks the payment condition of the special prescription and the patient, and performs virtual verification and cancellation on drug stored in the pharmacy according to the patient identifier and the prescription information of the hemodialysis drug in the special prescription, wherein the virtual verification and cancellation means that the drug is not purchased, and the virtual verification and cancellation determines the inventory condition of the hemodialysis drug of the patient in the pharmacy so as to perform drug claim later, thereby determining the detail data to be claimed of the drug of the patient.
It should be noted that the above solution of the preferred embodiment is only one specific implementation solution proposed in the present application, and other ways of determining detail data to be claimed of hemodialysis drugs corresponding to a special prescription in the drug management system according to the special prescription are all within the scope of protection of the present application.
In order to ensure consistency of detailed data to be claimed in the drug management system and the blood purification information system after virtual verification, in a preferred embodiment of the present application, after virtual verification of the hemodialysis drug in the drug management system based on the special prescription, the method further includes:
pushing the special prescription in the drug management system to the blood purification information system;
and updating detailed data to be claimed of the hemodialysis medicine in the blood purification information system according to the special prescription.
Specifically, because hemodialysis department staff need to go to a pharmacy to claim a medicine, after virtual verification of the hemodialysis medicine is completed, a special prescription list in the medicine management system is pushed to the blood purification information system, so that the blood purification information system updates detail data to be claimed of the hemodialysis medicine according to the special prescription list, and the hemodialysis department staff can determine the detail data to be claimed of the hemodialysis medicine.
It should be noted that the above solution of the preferred embodiment is only one specific implementation solution proposed in the present application, and other ways of ensuring consistency of detailed data to be claimed in the drug management system and the blood purification information system after virtual verification belong to the protection scope of the present application.
In order to enable the drug management system to obtain the corresponding special prescription, in a preferred embodiment of the present application, before determining details to be claimed of the hemodialysis drug corresponding to the special prescription in the drug management system according to the special prescription, the method further includes:
determining patient identification and medicine-opening quantity in an electronic prescription established by a doctor in an electronic medical record system;
judging whether the patient is a hemodialysis patient or not according to the patient identifier;
if yes, judging whether the annual prescription quantity corresponding to the prescription quantity exceeds the annual prescription upper limit of the hemodialysis medicine corresponding to the patient;
if not, generating the special prescription list in the electronic medical record system according to the electronic prescription list;
and pushing the special prescription list to the medicine management system.
Specifically, a patient selects a designated department for registration, a doctor sets an electronic prescription through an electronic medical record system, the electronic prescription comprises patient identification and prescription quantity, in a specific application scene of the application, a blood purification information system shares hemodialysis patient information to the electronic medical record system through an enterprise service bus, the hemodialysis patient information comprises the patient identification and the medication condition of the patient, whether the patient belongs to a hemodialysis patient is judged according to the patient identification, and if the patient is a hemodialysis patient, whether the annual prescription quantity corresponding to the prescription quantity exceeds the annual prescription upper limit of the hemodialysis medicine corresponding to the patient is continuously judged; if the patient is not hemodialysis, opening the medicine according to the medicine opening process of the common medicine, wherein the medicine opening process of the common medicine is the prior art and is not described herein again. And when the upper limit of the annual prescription amount is not exceeded, generating a special prescription according to the electronic prescription, and pushing the special prescription to a drug management system through an enterprise service bus.
It should be noted that the above solution of the preferred embodiment is only one specific implementation solution proposed in the present application, and other ways of obtaining a special prescription list all belong to the protection scope of the present application.
In order to keep the amount of the hemodialysis drug administered within a predetermined range, in a preferred embodiment of the present application, an upper annual drug administration amount limit of each hemodialysis drug corresponding to the hemodialysis patient is determined by a regression analysis method, and when it is determined that the annual drug administration amount corresponding to the drug administration amount exceeds the upper annual drug administration amount limit of the hemodialysis drug corresponding to the patient, the method further includes:
and prompting to reopen the prescription list in the electronic medical record system.
Specifically, in a specific application scenario of the present application, according to the certainty of the use type of the medicine of the patient and the controllability of the quantity, the only mutation parameter is: when the patient's condition is unstable or worsens, the type and quantity of the medicine used in hemodialysis each time are unpredictable, so a regression analysis method is adopted to dynamically calculate the annual upper limit of medicine use of the patient, wherein the specific process of the regression analysis method is the prior art, and is not described herein again. Because the annual prescription amount corresponding to the prescription amount exceeds the annual prescription amount upper limit, a special prescription can not be generated, and a doctor can be prompted to re-set the prescription in the electronic medical record system.
It should be noted that other ways to determine the upper limit of the annual drug opening amount of the hemodialysis drug can be adopted by those skilled in the art, and different ways do not affect the protection scope of the present application.
S102, determining claiming detail data of the hemodialysis medicine based on an actual verification result, wherein after the claiming operation corresponding to the special prescription is completed, the actual verification is performed on pharmacy storage of the hemodialysis medicine in the medicine management system.
Specifically, in a specific application scenario of the application, after a hemodialysis department worker completes a drug application according to a special prescription, a pharmacist performs actual verification and sales on drug stored in a pharmacy in a drug management system, so as to determine application detail data of the hemodialysis drug.
S103, determining consumption detail data of the hemodialysis medicine in the medicine management system, wherein the consumption detail data is pushed into the medicine management system by the blood purification information system.
Specifically, the blood purification information system pushes the consumption detail data of the hemodialysis drug to the drug management system, and thereby the consumption detail data is determined in the drug management system.
To accurately determine the consumption detail data of the hemodialysis drug, in a preferred embodiment of the present application, before determining the consumption detail data of the hemodialysis drug in the drug management system, the method further includes:
updating the consumption detail data of the patient in the blood purification information system according to the medicine use condition of the patient;
pushing the consumption detail data in the blood purification information system to the drug management system.
Specifically, in a specific application scenario of the present application, a hemodialysis department staff updates the consumption detail data of hemodialysis drugs of a patient in a blood purification information system according to the medication condition of the patient, and the blood purification information system pushes the consumption detail data to a drug management system through an enterprise service bus.
And S104, determining the detail data of the hemodialysis medicine according to the detail data to be claimed, the detail data to be claimed and the consumption detail data.
Specifically, the detailed data of the hemodialysis drug can be determined through the detail data to be claimed, the detail data to be claimed and the detail data to be consumed.
In order to make the patient timely know the detail data of the hemodialysis drug, in a preferred embodiment of the present application, after determining the detail data of the hemodialysis drug according to the detail data to be claimed, and the consumption detail data, the method further includes:
receiving a query request sent by the patient through a client;
providing the patient with the detailed data of the hemodialysis medication according to the query request.
Specifically, the patient can send an inquiry request through the client, and the detailed data of the hemodialysis drug corresponding to the patient is pushed to the patient according to the inquiry request, so that the patient can know the detailed data of the hemodialysis drug in time.
Through using above technical scheme, blood purifies information system, medicine management system and electronic medical record system and passes through the connection of enterprise service bus and set up unified patient's main index, include: determining detailed data to be claimed of hemodialysis drugs corresponding to a special prescription in the drug management system according to the special prescription; determining claim detail data for the hemodialysis medication based on results of actual verification and cancellation; determining consumption profile data for the hemodialysis medication in the medication management system; and determining the detail data of the hemodialysis drug according to the detail data to be claimed, the detail data to be claimed and the consumption detail data, so that an enterprise service bus is used for connecting and setting a patient main index, all medical system data channels are opened, the full-flow control of the hemodialysis patient drug administration is realized through a special prescription order and a virtual verification and marketing technology, the consistency of actual drug inventory and system inventory data is ensured, and the drug management efficiency and the patient satisfaction degree are improved.
In order to further illustrate the technical idea of the present invention, the technical solution of the present invention will now be described with reference to specific application scenarios.
Interpretation of terms
The ESB is called Enterprise Service Bus (Enterprise Service Bus) in its entirety. It is a product of combining traditional middleware technology with XML, Web service and other technologies. The ESB provides the most basic connection center in the network and is an essential element for constructing the nervous system of an enterprise. The emergence of the ESB changes the traditional software architecture, can provide a cheaper solution than the traditional middleware products, and at the same time, it can eliminate the technical difference between different applications, let different application servers operate in coordination, and realize the communication and integration between different services.
The Patient Master Index (EMPI) is a medical informatization terminology appearing at the end of the twentieth century, and is a Patient basic information retrieval directory. The main purpose of the method is to effectively associate a plurality of medical information systems together through unique patient identification in a complex medical system. The system can realize interconnection and intercommunication among all systems, and ensure the integrity and accuracy of personal information acquisition distributed in different systems for the same patient. In this embodiment, clinical data corresponding to hemodialysis patients are cleaned and stored in a clinical data center, and then clinic information data of the hemodialysis patients are acquired from the clinical data center, and then the clinic information data are automatically merged according to rules based on a patient main index EMPI engine to establish the patient main index.
The embodiment of the invention provides a method for determining detailed data of hemodialysis drugs, which is characterized in that a drug management system, an electronic medical record system and a blood purification information system are connected through an enterprise service bus, unified patient main indexes are set, data channels of various medical systems are opened, full-process drug administration management and control of hemodialysis patients are realized through special prescription and virtual verification and marketing technologies, the consistency of actual drug inventory and system inventory data is ensured, and the drug management efficiency and the patient satisfaction are improved.
Fig. 2 is a schematic flow chart of the method for determining the detail data of the hemodialysis drug, which includes the following steps:
step S201, determining detail data to be claimed of hemodialysis drugs in the drug management system according to a special prescription;
wherein the special prescription is pushed to the drug management system by the electronic medical record system.
Step S202, determining claim detail data of the hemodialysis medicine based on an actual verification and cancellation result in a medicine management system;
wherein the actual verification and cancellation are performed on the pharmacy deposit of the hemodialysis drug in the drug management system after the claim operation corresponding to the special prescription is completed.
Step S203, determining consumption detail data of the hemodialysis medicine in the medicine management system;
wherein the consumption specification data is pushed by the blood purification information system into the drug management system.
Step S204, determining the detail data of the hemodialysis medicine according to the detail data to be claimed, the claim detail data and the consumption detail data.
As shown in fig. 3, step S201 further includes the following steps:
step S301, the electronic medical record system generates a special prescription and pushes the special prescription to a medicine management system;
step S302, the patient finishes payment and goes to a pharmacy to take medicine;
step S303, checking the special prescription order received by the drug management system and the payment condition of the patient by a pharmacist;
step S304, the drug management system performs virtual verification (after verification and re-distribution), and updates detailed data to be claimed of hemodialysis drugs. The virtual verification refers to verification but no drug delivery.
As shown in fig. 4, step S301 further includes the following steps:
step S401, a patient selects a designated department to register;
step S402, a doctor prescribes a prescription (containing the name and the number of medicines) through an electronic medical record system, wherein the blood purification information system shares hemodialysis patient information to the electronic medical record system through an enterprise service bus, and the hemodialysis patient information comprises patient identification and the medication condition of a patient;
step S403, automatically judging whether the patient belongs to a hemodialysis type patient, executing step S404 when the judgment result is yes, and executing step S405 when the judgment result is no;
step S404, judging whether the quantity of the medicines exceeds the upper limit of the quantity of the medicines, if the judgment result is no, executing step S406, and if the judgment result is yes, executing step S407;
wherein, according to the certainty of the use type of the medicine of the patient and the controllability of the quantity, the only mutation parameters are as follows: when the patient's condition is unstable or worsens, the type and quantity of the medicine used in hemodialysis each time are unpredictable, so a regression analysis method is adopted to dynamically calculate the annual upper limit of medicine use of the patient, wherein the specific process of the regression analysis method is the prior art, and is not described herein again.
Step S405, opening the medicines according to the opening flow of the ordinary medicines, wherein the opening flow of the ordinary medicines is the prior art and is not described herein again.
Step S406, the electronic medical record system generates a special prescription and pushes the special prescription to a medicine management system;
step S407, reminding the doctor that the upper limit of the medicine amount is exceeded, and please re-open the prescription list to execute step S402.
As shown in fig. 5, step S304 is followed by:
step S501, the medicine management system pushes the special prescription to the blood purification information system;
step S502, the blood purification information system updates detailed data to be claimed of hemodialysis drugs of the patient according to the basic information, the types and the quantity of the drugs of the patient on the special prescription.
As shown in fig. 6, step S202 further includes the following steps:
step S601, a pharmacist generates and prints corresponding drug credentials (including basic information of a patient) to the patient through a drug management system;
step S602, the patient goes to a hemodialysis department for medication by the aid of the drug certificate;
step S603, the hemodialysis department staff goes to a pharmacy to take the medicine according to the medicine credential provided by the patient and the special prescription information in the system;
in step S604, the pharmacist performs actual verification of the drug in the drug administration system, and updates the hemodialysis drug claim detail data.
As shown in fig. 7, step S203 further specifically includes:
step S701, the patient completes the treatment;
step S702, the hemodialysis department staff updates the hemodialysis medicine consumption detail data of the patient in the blood purification information system and pushes the hemodialysis medicine consumption detail data to the medicine management system.
Fig. 8 is a schematic view illustrating a flow of a hemodialysis drug in an embodiment of the present invention.
After step S204, the method further includes:
receiving an inquiry request sent by a patient through a client, and providing detailed data of hemodialysis drugs for the patient according to the inquiry request.
In order to achieve the above technical object, an embodiment of the present application further provides an apparatus for determining hemodialysis drug detail data, where a blood purification information system, a drug management system, and an electronic medical record system are connected by an enterprise service bus and set a unified patient master index, as shown in fig. 9, including:
a first determining module 901, configured to determine details of a to-be-claimed item of a hemodialysis drug in the drug management system, which corresponds to a special prescription, according to the special prescription, where the special prescription is pushed into the drug management system by the electronic medical record system;
a second determining module 902, configured to determine claim detail data of the hemodialysis drug based on a result of actual verification and cancellation, where the actual verification and cancellation are performed on pharmacy storage of the hemodialysis drug in the drug management system after a claim operation corresponding to the special prescription is completed;
a third determining module 903, configured to determine consumption detail data of the hemodialysis drug in the drug management system, wherein the consumption detail data is pushed into the drug management system by the blood purification information system;
a fourth determining module 904, configured to determine the detail data of the hemodialysis drug according to the to-be-claimed detail data, the claim detail data, and the consumption detail data.
Through the above description of the embodiments, those skilled in the art will clearly understand that the present invention may be implemented by hardware, or by software plus a necessary general hardware platform. Based on such understanding, the technical solution of the present invention can be embodied in the form of a software product, which can be stored in a non-volatile storage medium (which can be a CD-ROM, a usb disk, a removable hard disk, etc.), and includes instructions for causing a computer device (which can be a personal computer, a server, or a network device, etc.) to execute the method according to the implementation scenarios of the present invention.
Those skilled in the art will appreciate that the figures are merely schematic representations of one preferred implementation scenario and that the blocks or flow diagrams in the figures are not necessarily required to practice the present invention.
Those skilled in the art will appreciate that the modules in the apparatus may be distributed in the apparatus according to the description of the implementation scenario, or may be located in one or more apparatuses different from the present implementation scenario with corresponding changes. The modules of the implementation scenario may be combined into one module, or may be further split into a plurality of sub-modules.
The above-mentioned invention numbers are merely for description and do not represent the merits of the implementation scenarios.
The above disclosure is only a few specific implementation scenarios of the present invention, however, the present invention is not limited thereto, and any variations that can be made by those skilled in the art are intended to fall within the scope of the present invention.
Claims (8)
1. A method of determining hemodialysis medication detail data, wherein a blood purification information system, a medication management system, and an electronic medical record system are connected via an enterprise service bus and set up a unified patient master index, the method comprising:
determining detail data to be claimed of hemodialysis drugs corresponding to a special prescription in the drug management system according to the special prescription, wherein the special prescription is pushed into the drug management system by the electronic medical record system;
determining claim detail data of the hemodialysis drug based on a result of actual verification and cancellation, wherein the actual verification and cancellation are performed on pharmacy storage of the hemodialysis drug in the drug management system after a claim operation corresponding to the special prescription is completed;
determining consumption profile data for the hemodialysis medication in the medication management system, wherein the consumption profile data is pushed into the medication management system by the blood purification information system;
determining the detail data of the hemodialysis medicine according to the detail data to be claimed, the detail data to be claimed and the consumption detail data;
the special prescription list comprises a patient identifier and prescription information of the hemodialysis medicine, and the detail data to be claimed of the hemodialysis medicine corresponding to the special prescription list in the medicine management system is determined according to the special prescription list, and specifically comprises the following steps:
virtually checking the hemodialysis medication in the medication management system based on the special prescription order;
determining the itemized data to be claimed based on the result of the virtual core cancellation.
2. The method of claim 1, further comprising, after virtually checking the hemodialysis medication in the medication management system based on the special prescription order:
pushing the special prescription in the drug management system to the blood purification information system;
and updating detailed data to be claimed of the hemodialysis medicine in the blood purification information system according to the special prescription.
3. The method of claim 1, further comprising, prior to determining, from a special prescription, details to be claimed of a hemodialysis medication in the medication management system corresponding to the special prescription, further comprising:
determining patient identification and medicine-opening quantity in an electronic prescription established by a doctor in an electronic medical record system;
judging whether the patient is a hemodialysis patient or not according to the patient identifier;
if yes, judging whether the annual prescription quantity corresponding to the prescription quantity exceeds the annual prescription upper limit of the hemodialysis medicine corresponding to the patient;
if not, generating the special prescription list in the electronic medical record system according to the electronic prescription list;
and pushing the special prescription list to the medicine management system.
4. The method of claim 3, wherein determining an upper annual bolus amount limit for each hemodialysis medication corresponding to the patient using regression analysis, and when it is determined that the annual bolus amount corresponding to the bolus amount exceeds the upper annual bolus amount limit for the hemodialysis medication corresponding to the patient, further comprising:
and prompting to reopen the prescription list in the electronic medical record system.
5. The method of claim 1, further comprising, prior to determining consumption detail data for the hemodialysis medication in the medication management system:
updating the consumption detail data of the patient in the blood purification information system according to the medicine use condition of the patient;
pushing the consumption detail data in the blood purification information system to the drug management system.
6. The method of claim 1, further comprising, after determining the particulars data of the hemodialysis medication from the pending particulars data, the claiming particulars data, and the consumption particulars data:
receiving a query request sent by a patient through a client;
providing the patient with the detailed data of the hemodialysis medication according to the query request.
7. An apparatus for determining hemodialysis medication detail data, wherein a blood purification information system, a medication management system and an electronic medical record system are connected via an enterprise service bus and set up a unified patient master index, comprising:
the first determination module is used for determining detailed data to be claimed of hemodialysis drugs corresponding to a special prescription in the drug management system according to the special prescription, wherein the special prescription is pushed into the drug management system by the electronic medical record system;
a second determination module, configured to determine claim detail data of the hemodialysis drug based on a result of actual verification and cancellation, where the actual verification and cancellation are performed on pharmacy storage of the hemodialysis drug in the drug management system after a claim operation corresponding to the special prescription is completed;
a third determination module for determining consumption profile data of the hemodialysis drug in the drug management system, wherein the consumption profile data is pushed into the drug management system by the blood purification information system;
a fourth determining module, configured to determine detail data of the hemodialysis drug according to the to-be-claimed detail data, the claim detail data, and the consumption detail data;
the special prescription list comprises a patient identifier and prescription information of the hemodialysis medicine, and the detail data to be claimed of the hemodialysis medicine corresponding to the special prescription list in the medicine management system is determined according to the special prescription list, and specifically comprises the following steps:
virtually checking the hemodialysis medication in the medication management system based on the special prescription order;
determining the itemized data to be claimed based on the result of the virtual core cancellation.
8. A computer-readable storage medium having stored therein instructions which, when run on a terminal device, cause the terminal device to perform the method of determining hemodialysis drug detail data of any one of claims 1-6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910722704.2A CN110444268B (en) | 2019-08-06 | 2019-08-06 | Method and equipment for determining detail data of hemodialysis medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910722704.2A CN110444268B (en) | 2019-08-06 | 2019-08-06 | Method and equipment for determining detail data of hemodialysis medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110444268A CN110444268A (en) | 2019-11-12 |
| CN110444268B true CN110444268B (en) | 2021-12-03 |
Family
ID=68433696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910722704.2A Active CN110444268B (en) | 2019-08-06 | 2019-08-06 | Method and equipment for determining detail data of hemodialysis medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110444268B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102708529A (en) * | 2012-05-16 | 2012-10-03 | 北京航空航天大学 | Drug storage information managing system for pharmacy |
| CN106157211A (en) * | 2015-04-27 | 2016-11-23 | 苏州市艾信物联网技术有限公司 | A kind of Code in Hazardous Special Locations drug control method |
| CN108133747A (en) * | 2017-12-27 | 2018-06-08 | 苏州麦迪斯顿医疗科技股份有限公司 | A kind of medical supplies warehouse-out method, device, terminal and computer-readable medium |
| CN109636635A (en) * | 2018-12-13 | 2019-04-16 | 平安医疗健康管理股份有限公司 | Recognition methods, device, terminal and the computer readable storage medium write a prescription in violation of rules and regulations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4873384B2 (en) * | 2004-09-16 | 2012-02-08 | オリンパス株式会社 | Medical practice management method, management server and medical practice management system using the same |
-
2019
- 2019-08-06 CN CN201910722704.2A patent/CN110444268B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102708529A (en) * | 2012-05-16 | 2012-10-03 | 北京航空航天大学 | Drug storage information managing system for pharmacy |
| CN106157211A (en) * | 2015-04-27 | 2016-11-23 | 苏州市艾信物联网技术有限公司 | A kind of Code in Hazardous Special Locations drug control method |
| CN108133747A (en) * | 2017-12-27 | 2018-06-08 | 苏州麦迪斯顿医疗科技股份有限公司 | A kind of medical supplies warehouse-out method, device, terminal and computer-readable medium |
| CN109636635A (en) * | 2018-12-13 | 2019-04-16 | 平安医疗健康管理股份有限公司 | Recognition methods, device, terminal and the computer readable storage medium write a prescription in violation of rules and regulations |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110444268A (en) | 2019-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Scullin et al. | An innovative approach to integrated medicines management | |
| JP6457097B2 (en) | Healthcare data interchange system and method | |
| St Peter et al. | New models of CKD care including pharmacists: improving medication reconciliation and medication management | |
| US8918385B1 (en) | Methods and systems of correlating electronic pharmacy data and electronic medical records | |
| US11923052B2 (en) | Electronic healthcare record data blockchain system and process | |
| AU2001256799A1 (en) | A method of internet-based medical record database configuration and system thereof by mutual certification between patient and doctor | |
| CN104981808A (en) | System and apparatus for electronic patient care | |
| CN109461485A (en) | Prescription outflow takes prescription method and server | |
| Angeles | Blockchain-based healthcare: Three successful proof-of-concept pilots worth considering | |
| US11568397B2 (en) | Providing a financial/clinical data interchange | |
| Epstein et al. | Controlled substance reconciliation accuracy improvement using near real-time drug transaction capture from automated dispensing cabinets | |
| CN110444268B (en) | Method and equipment for determining detail data of hemodialysis medicine | |
| US20140236612A1 (en) | Multi-access health care provider portal | |
| CN112259253A (en) | Medical prescription auditing system and method | |
| Valenti et al. | Nurse‐led telephone follow‐up for early palliative care patients with advanced cancer | |
| Shen et al. | Development of an integrated and comprehensive clinical trial process management system | |
| Ives et al. | Resilience and ongoing quality care for cancer clinical trials during COVID‐19: experience from a tertiary hospital in Australia | |
| Beattie et al. | Improving wait time from referral to opiate replacement therapy in a drug recovery service | |
| US8660859B1 (en) | Systems and methods for executing an electronic pharmacy program that requires access to an electronic medical record | |
| CN113808761A (en) | Online prescription transfer method and system | |
| CN112700837A (en) | Stable coronary heart disease traditional Chinese medicine service system based on mobile internet platform | |
| Nappo et al. | Improved outpatient haemodialysis adequacy using queued schedules | |
| US20190115100A1 (en) | Systems and Methods of Processing and Reconciling Healthcare Related Claims | |
| CN113611384B (en) | Method and system for self-checking and self-correcting medical institution terminal visit data | |
| CA3193187A1 (en) | System and method for patient data provision consumption, and royalty processing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |